It is now established that sustained arterial hypertension can be produced experimentally in animals by interference with the blood supply of the kidney (1, 2, 3). Furthermore, this experimental hypertension can be relieved either b-y removing the interference or by excising the entire offended kidney (3, 4) . There seems little doubt that this type of hypertension has a clinical counterpart in the naturally occurring hypertension of certain patients whose arterial pressure has been lowered after removal of an " ischemic " kidney (5 to 9).
It has also been demonstrated that the experimental hypertension associated with renal " ischemia" is humoral in nature (4, 10, 11) , and probably due to the release of abnormal amounts of pressor substances by the offended kidney (11, 12, 13) . This revived interest in the original work of Tigerstedt and Bergman (14) who in 1898 prepared from kidneys a pressor extract which they called " Renin." Modern methods of purification and analysis have revealed that the pressor agent in Renin is probably an enzyme (15, 16) which reacts with a pseudoglobulin fraction of blood to form a vasoconstrictor substance called "Angiotonin " (17) or " Hypertensin" (18) .
Evidence is accumulating that a vasoconstrictor substance similar to, if not identical with, " Angiotonin " or " Hypertensin " is present in abnormal amounts in the blood of animals with experimentally produced renal " ischemia ", and of certain patients with naturally occurring hypertension (18, 19, 20) . Therefore, it has been postulated that in these instances Angiotonin may be the humoral agent responsible for the elevated arterial pressure. These considerations made it seem essential to determine whether the adminis-1 Presented before The Society for Clinical Investigation at the annual meeting at Atlantic City, May 5, 1941. tration of Angiotonin to normal subjects would produce arterial hypertension similar to that observed clinically in human cases.
METHODS
The Angiotonin 2 was administered intravenously, either full strength in single injections ranging from 0.1 cc. to 2 cc., or as a 10 per cent solution (in saline) by constant infusion at rates up to 5 cc. per minute.
Arterial pressure was determined by the Hamilton manometer (21) in the femoral artery, or by the usual auscultatory method in the brachial artery. Venous pressure was measured in the antecubital vein either by the Hamilton manometer or by the method of Moritz and von Tabora (22) . Pulse rate was counted from one of the several tracings obtained.
Temperature of the skin was measured by thermal junctions lightly attached to the skin by adhesive strips. Usually the pads of the fingers and toes, and occasionally points on the face, chest or forearms were selected for temperature measurements. Rectal temperature was determined by a thermal junction inserted at least 5 cm. above the internal rectal sphincter. The galvanometer allowed the detection of changes of 0.1°C. The room was draught-free and was maintained at a temperature as constant as possible.
Blood flow in the hand, forearm or calf was measured plethysmographically (23, 24) . Measurements were made both in the normal resting condition, and also after full local vasodilatation had been induced by a 5-minute period of arterial occlusion (25) . The latter type of measurements have been termed "reactive-hyperemia blood flows." Three minutes were allowed for recovery between each 5-minute period of arterial occlusion when such measurements were being made.
Circulation time was determined by the sodium cyanide method (26) . Cardiac output was estimated in both the supine and erect positions on the ballistocardiographs of Dr. Isaac Starr (27) , who very kindly made the records and did the calculations. Spinal fluid pressure, vital capacity, electrocardiograms, teleoroentgenograms and kymograms were obtained by the usual techniques. Dur- C-%--t-00 0'it-to -0% %--4' 00'4 00-00"1400 "14 " (Figures 1, 2, 3 ). This increase in pulse pressure was Figure 4) . Incidentally, the hypertensive effect of a given dose of Angiotonin was greatly enhanced after atropinization.
With the rise of arterial pressure after Angiotonin, venous pressure also rose, but more slowly, reaching its peak about 1 minute after the maximum rise in arterial pressure (Tables I, II, Figures 1, 2, 3) . During the rise of venous pressure, the neck veins often became visibly more distended.
Respiration usually quickened slightly, but there was never any subjective sensation of dyspnea. However, the vital capacity decreased significantly (Tables I, II, Figures 2, 3) .
Rectal temperature was never significantly affected by the administration of Angiotonin but the temperature of the skin usually decreased slightly (Tables I, II, Figures 2, 3) . In many subjects definite pallor was apparent. Angiotonin when injected inztradermally (0.1 cc.) in 5 subjects produced definite local blantching, but not so marked or widespread as that produced bv a solution (1: 1000) of epinephrine (0.1 cc.).
Blood flow in the limbs usually decreased moderately, but not always (Tables I, II) . Characteristically, in the limbs the responise was phasic, consisting of an initial increase in blood flow, followed by a decrease and finally a return to the control level ( Figure 5 ). The changes in volume of the limbs always reflected the alterations in blood flow.
Some interest was attached to the nature of the initial increase in blood flow which occurred in the limbs after an intravenous injection of Angiotonin, since evidence was obtained that the local action of Angiotonin is vasoconstrictor: Minute amounts (up to 0.1 cc.) of Angiotonin injected directly into the femoral artery of 4 subjects caused only vasoconstriction locally in the calf ( Figure 6 ). The initial vasodilatation after intravenous injection appeared simultaneously in the forearm and calf with the first rise of arterial pressure ( Figure 5 ) and often before the expected arrival of the Angiotonini in the part, as calculated from the circulation time. The appearance and amplitude of this inicrease in blood flow were niot directly related to the size of the dose of Angiotonin or to the height to which the arterial pressure subsequently rose. These facts stugested that this initial vasodilatation was due to some mechanism other than the local action of Angiotonin. That it probably was the result of sympathetic vasomotor activity was demonstrated in a subject with a unilateral (right) cervical sympathectomy performed 9 Figure   10 . The letters correspond to the times indicated at the top of Figure 9 . pertension subsided after the infusion of Angiotonin was stopped (Table III, Figure 8 ). The cardiac output (blood flow to the entire body) nmeasured ballistocardiographically in the supine and upright positions decreased after Angiotonin, both when calculated as cc. per minute per pound, and as cc. per beat 3 (Table IV) . In one subject ( Figure 9 ) after a single injection of Angiotonin, with a moderate rise of arterial and venous pressures, the change in output per beat was negligible, probably because of the bradycardia. However, during an infusion of Angiotonin, which resulted in a prolonged marked rise of arterial and venous pressures, there was a profound decrease in the cardiac output per beat as well as per minute (Figures 9, 10) .
The arm-to-carotid sinus circulation time usually increased, often only slightly, but occasionally considerably (Tables I, II) .
The electrocardiograms showed no significant changes other than the bradycardia (Figure 4) . X-ray examinations of the heart showed in 6 of 8 subjects a small but definite increase in the cardiac size (Table V, Figure 11 ). Kymograms usually showed a slight decrease in the amplitude of the cardiac pulsations. In some subjects, in addition to the increase in the cardiac shadow, there was also an increase in the pulmonary markings.
The effects of Angiotonin administered intravenously subsided gradually in 4 to 10 minutes after the cessation of the administration, whether by continuous infusion or by single injection. The most interesting aspect of the arterial hypertension produced by Angiotonin is the associated evidence of " myocardial failure " occurring in otherwise normal individuals. An increase in venous pressure, decrease in vital capacity, increase in cardiac size, decrease in cardiac output and increase in circulation time, all important signs of heart failure, were frequently found. The mode by which Angiotonin could produce heart failure is difficult to explain, unless it exerts a direct " toxic " action on the myocardium. The experimental evidence in animals is against this explanation. On the contrary, Angiotonin seems to exert a stimulating or "tonic " effect on the myocardium (isolated heart), increasing its output and efficiency (29, 30) .
It would appear that in man Angiotonin produces marked and generalized peripheral vasoconstriction, since it causes not only a rise in arterial pressure but also a decrease in cardiac output. The effects on cardiac output here reported are in essential agreement with those of Bradley and Parker (32) . Likewise, the blood flow in every area in which measurements have been made, including the renal (33, 34) , has been found to decrease after Angiotonin, at least initially. The peripheral vasoconstriction must be primarily on the arterial (arteriolar) side of the circulation since the rise of arterial pressure precedes 'the increase in venous pressure and the other signs of "myocardial failure."
Except for the rise in venous pressure and the decrease in cardiac output, the circulatory effects of Angiotonin, though definite when compared with the control measurements of the same sub-' ject, usually are not so great as to be clearly abnormal. Hence the increase in venous pressure and decrease in cardiac output can be said to be the outstanding characteristics of the Angiotonin hypertension.
It is difficult to judge whether naturally occurring hypertension is similar to the hypertension due to Angiotonin. However, one can state that, as commonly accepted, essential hypertension is not entirely similar to the hypertension of Angiotonin. The chief difference is the absence of a significant elevation of venous pressure such as was observed after Angiotonin. On the other hand, as Starr has pointed out, a decrease in cardiac output, measured ballistocardiographically, is found in a considerable number of patients with essential hypertension (34) . Furthermore, the amount of the decrease is about the same as that produced by Angiotonin (35) . A possible explanation for the absence of the increased venous pressure and the other signs of " myocardial failure " in established cases of essential hypertension is that such signs may have been present initially, only to disappear after sufficient time had elapsed for the adjustments of " compensation " to take place.
One form of naturally occurring hypertension, namely that associated with acute hemorrhagic nephritis, does seem to be similar to the hypertension of Angiotonin. Both are characterized by an elevation of venous pressure and by x-ray evidence of increases in cardiac size and pulmonary congestion (36) . These similarities may be apparent not only because of the sudden onset and acute nature of the two types, but also because of the availability of control or recovery measurements in the same individuals for comparison.
The blood flow in the limbs after the administration of Angiotonin tends to decrease, but remains under the control of the sympathetic nervous system. The resting blood flow, after an initial phasic variation, may be slightly, or even considerably, below the control level, but sympathetic vasodilatation and vasoconstriction can occur as before in response to appropriate stimuli. In this respect the hypertension due to Angiotonin is compatible with essential hypertension. The variable amount of the increase in circulation time in different individuals after Angiotonin could be explained entirely on the variable amount of associated decrease in the peripheral blood flow (37) .
That Angiotonin produces local vasoconstriction is established not only from the evidence already cited, but also by the observations on its vasoconstrictor effects when injected intradermally or intra-arterially. But it is important that the peripheral vasoconstriction caused by Angiotonin can be released by physiologic procedures producing vasodilatation. Thus the reactive-hyperemia blood flows obtained during full local vasodilatation after a 5-minute period of arterial occlusion increased along with the arterial pressure. This demonstrates that there is no danger of an inadequate blood flow with tissue anoxia in the extremities during the action of Angiotonin. On the contrary, because of the higher arterial pressure, the blood flow, if needed, can actually be greater than normal.
These observations on the reactive-hyperemia blood flow during the hypertension produced by Angiotonin are similar to those obtained during other pressor procedures (38) . They emphasize the direct relationship which exists in a given individual between arterial pressure and blood flow in the limbs under controlled vasodilatation. But again, because of the wide scattering of the values for blood flow obtained in different individuals, whether normal or hypertensive, such measurements are of questionable value in estimating the degree and nature of the peripheral resistance to blood flow in a random subject or in two groups of individuals. It can be stated, however, that the reactive-hyperemia blood flows obtained during the hypertension due to Angiotonin are comparable with those obtained in young individuals with naturally occurring hypertension. Therefore, they are consistent with the conclusion that the increased peripheral resistance to blood flow in such hypertensive patients also can be released by similar physiologic vasodilatation.
The prevention of bradycardia after Angiotonin by atropine would indicate that the cardiac slowing is probably vagal in origin. Furthermore, the fact that the hypertensive effect of a given dose of Angiotonin is enhanced after atropine shows that the bradycardia is an important moderator mechanism. Probably another such moderator mechanism, though less effective, is the initial sympathetic vasodilatation in the limbs after Angiotonin.
It was surprising to find that no significant rise in spinal fluid pressure occurred after Angiotonin, in spite of considerable increases of arterial and venous pressures. This was interpreted as indicating that after Angiotonin a marked vasoconstriction occurs in the small vessels of the cerebrospinal contents, with a probable decrease in blood flow. This change was thought to be analogous to the decrease in volume and blood flow which may occur in the limbs after Angiotonin along with a rise of arterial and venous pressures.
The finding of no significant difference in the pressor response to the cold test of Hines and Brown in the same subject when normal, and when hypertensive from Angiotonin, is of considerable interest. It casts doubt upon the usual explanation of why there should be a hyper-reactor response in hypertensive, or potentially hypertensive, individuals. This explanation postulates a greater amount of sympathetic vasoconstrictor " reserve " in such persons, due to a state of relative sympathetic vasodilatation which, in turn, is a moderator response to the presence of a circulating pressor substance. This greater reserve is called into play by a strong vasoconstrictor stimulus, such as the cold test, giving a " hyper-reactor" response. The experiments here reported would indicate that some other factor, possibly hereditary, is responsible for the hyperreactivity of the sympathetic nervous system in certain individuals, and that such hyper-reactivity is not necessarily imposed upon a normal sympathetic nervous system by incipient or actual hypertension.
The symptoms produced by Angiotonin were usually mild, but somewhat proportional to the dosage, and to the resultant rise in arterial pressure. 5. The electrocardiogram reveals no important changes except bradycardia.
6. The temperature of the skin usually decreases, but remains responsive to alterations of body temperature.
7. Blood flow measured plethysmographically in the limbs tends to decrease but remains under the control of the sympathetic nervous system. 8. Reactive-hyperemia blood flow (measured during full local vasodilatation produced by a 5-minute period of arterial occlusion) increases with the rise of arterial pressure.
9. The pressor response to the cold test of Hines and Brown is not altered during the hypertension.
10. Mild symptoms of dizziness, substernal oppression, headache, nausea or palpitation may be noted.
11. The effects subside 4 to 10 minutes after the cessation of administration, whether by single injection or by continuous infusion.
12. Injected intradermally, Angiotonin produces local blanching of the skin. 13 . Injected intra-arterially, it produces vasoconstriction in the muscular parts supplied by the artery.
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